Spyglass Pharma Inc (SGP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2008 | 12-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 96,358 | 16,268 | 15,849 | 3,373,000 | 2,279,000 |
| Marketable Securities | 11,078 | N/A | 24,468 | 5,000 | 32,000 |
| Receivables | 431 | 423 | 123 | 2,816,000 | 2,841,000 |
| Inventories | N/A | N/A | N/A | 3,114,000 | 4,073,000 |
| Income taxes - deferred | N/A | N/A | N/A | 435,000 | 349,000 |
| TOTAL | $108,768 | $17,406 | $40,615 | $10,971,000 | $10,846,000 |
| Non-Current Assets | |||||
| PPE Net | 2,339 | 2,168 | 449 | 6,833,000 | 7,016,000 |
| Intangibles | 0 | 0 | 0 | 8,932,000 | 9,941,000 |
| Other Non-Current Assets | 4,759 | 3,744 | 86 | 1,381,000 | 1,353,000 |
| TOTAL | $7,098 | $5,912 | $535 | $17,146,000 | $18,310,000 |
| Total Assets | $115,866 | $23,318 | $41,150 | $28,117,000 | $29,156,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 245,000 | 461,000 |
| Accounts payable and accrued liabilities | 2,696 | 1,978 | 639 | 1,677,000 | 1,762,000 |
| Accrued Expenses | 2,182 | 1,282 | 609 | 1,010,000 | 995,000 |
| Other current liabilities | 3,706 | 4,089 | 341 | N/A | N/A |
| TOTAL | $8,584 | $7,791 | $1,589 | $5,193,000 | $6,043,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 7,931,000 | 9,019,000 |
| Other Non-Current Liabilities | 206,119 | 76,001 | 72,546 | 2,913,000 | 2,008,000 |
| TOTAL | $206,119 | $76,001 | $72,546 | $12,395,000 | $12,728,000 |
| Total Liabilities | $214,703 | $83,792 | $74,135 | $17,588,000 | $18,771,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,427 | N/A | N/A | 1,626,412 | 1,621,354 |
| Common Shares | 0 | 0 | 0 | 1,059,000 | 1,055,000 |
| Retained earnings | -104,730 | -64,861 | -35,698 | 9,181,000 | 7,856,000 |
| Other shareholders' equity | 0 | 0 | 0 | 587,000 | 1,966,000 |
| TOTAL | $-98,837 | $-60,474 | $-32,986 | $10,529,000 | $10,385,000 |
| Total Liabilities And Equity | $115,866 | $23,318 | $41,150 | $28,117,000 | $29,156,000 |